Skip to content

Collibra MCP for faster FDA / EMA regulatory response in Life Sciences

For life sciences organizations, assembling supporting evidence is a manual process: Clinical data lineage reconstructed from memory and email threads. GxP asset ownership is called up system by system. ALCOA+ evidence is often compiled by hand from disconnected repositories. The result is a response that is slow, incomplete, and difficult to defend. Sponsors typically have just 14 business days to respond to regulators. Evidence must be available, complete, traceable, and defensible.